Page last updated: 2024-09-03

tyrosyl-isoleucyl-glycyl-seryl-arginine and Liver Neoplasms

tyrosyl-isoleucyl-glycyl-seryl-arginine has been researched along with Liver Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cai, SX; Huang, QP; Li, P; Qin, J; Wu, ZZ; Xiao, GH1

Other Studies

1 other study(ies) available for tyrosyl-isoleucyl-glycyl-seryl-arginine and Liver Neoplasms

ArticleYear
Inhibition of adhesion of hepatocellular carcinoma cells to basement membrane components by receptor competition with RGD- or YIGSR-containing synthetic peptides.
    Biorheology, 2003, Volume: 40, Issue:4

    Topics: Basement Membrane; Binding, Competitive; Carcinoma, Hepatocellular; Cell Adhesion; Collagen Type IV; Dose-Response Relationship, Drug; Fibronectins; Humans; Laminin; Liver Neoplasms; Micromanipulation; Neoplasm Proteins; Oligopeptides; Tumor Cells, Cultured

2003